Clinical Trial Update: Single Dose Study of MK-2060 to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Older Japanese Participants on Dialysis (MK-2060-012) [Phase 1]

View source ↗

Summary

This Phase 1 single-dose study of MK-2060 in older Japanese participants on dialysis completed, with results posted, evaluating safety, tolerability, pharmacoki…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• MK-2060

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: End-Stage Renal Disease (ESRD), End-Stage Kidney Disease (ESKD) | Phase 1 | Status: COMPLETED | Results posted: 2025-03-14